Michele is 78 years old and has been a multiple myeloma survivor for 22 years, as well as a breast cancer survivor for 30 years. She was diagnosed with IgG Kappa myeloma in 2003 after her doctor noticed low hematocrit and hemoglobin levels. Although the diagnosis came as a shock, Michele was given great hope by the myeloma specialists who guided her care. Since then, she has been incredibly blessed to live a normal, active, and joyful life, pausing only briefly for a stem cell transplant and CAR-T therapy.
Over the years, Michele has received many treatments, including thalidomide, dexamethasone, Revlimid, Pomalyst, Darzalex, Elotuzumab, and Cytoxan. She underwent a stem cell transplant and later participated in a CAR-T clinical trial, which brought her into complete remission for the first time in 19 years, a remission that lasted about two and a half years. She is currently on Sarclisa and Venclexta.
Michele attributes her ability to live well with myeloma to the unwavering support of her husband, family, and friends, staying active, maintaining a positive attitude, and benefiting from the many new treatments developed through research.
She is the proud mother of four children, grandmother of six, and great-grandmother of five. One of Michele’s goals at diagnosis was to live long enough to celebrate her grandchildren’s graduations and weddings, a goal she has joyfully achieved.
Michele was fortunate to have been retired at the time of her diagnosis, which gave her time to attend to her disease. She enjoys playing golf, traveling extensively, playing bridge, attending cultural events, and embracing life to the fullest. As a HealthTree Coach, she offers support, encouragement, and hope to other myeloma patients, helping them see that it is possible to live well with myeloma.